Agarwal K, Xu J, Gane EJ, Nguyen TT, et al. Safety, pharmacokinetics, and antiviral activity of ABI-H2158, a hepatitis B virus core inhibitor: a randomized, placebo-controlled Phase 1 study. J Viral Hepat 2022 Oct 27. doi: 10.1111/jvh.13764.
PMID: 36302125